GlassScriptPhysician profile
Leigh Ann Cochran
NPI 1134608243
$1,906.26
in general payments reported to CMS, 2019-2025
24 companies · $624 in 2025
The $624 reported for 2025 was more than what 79% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $259 · 2022: $47.69 · 2023: $409 · 2024: $567 · 2025: $624.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,599.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,599.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $645.46 | 2021-2025 | Lifevest |
| Boston Scientific Corporation | $197.19 | 2024-2025 | Lux-Dx Insertable Cardiac Monitor, Emblem Mri S-Icd, Lithovue Empower |
| Philips North America LLC | $192.89 | 2023-2025 | Mcot, (5044) Mcot, (Ck4) Mcot |
| Novartis Pharmaceuticals Corporation | $170.68 | 2021-2024 | |
| Janssen Pharmaceuticals, INC | $141.05 | 2021-2024 | Xarelto |
| Stryker Corporation | $95.80 | 2025 | Artix Mt, Clottriever Bold Catheter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.85 | 2021 | |
| Scpharmaceuticals INC. | $47.76 | 2024 | |
| Lexicon Pharmaceuticals, INC. | $37.48 | 2024 | |
| Novo Nordisk INC | $35.92 | 2024-2025 | Wegovy, Rybelsus, Ozempic |
| Abbott Laboratories | $35.61 | 2024 | Confirm Rx |
| Amgen INC. | $32.73 | 2023-2024 | Repatha |
| Astrazeneca Pharmaceuticals LP | $28.66 | 2021-2023 | Brilinta |
| Kestra Medical Technology Services, INC. | $22.58 | 2025 | Assure Wcd |
| Merck Sharp & Dohme LLC | $19.47 | 2024 | Verquvo |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $19.30 | 2025 | Eliquis |
| Atricure, INC. | $18.39 | 2024 | |
| Irhythm Technologies, INC. | $17.78 | 2024 | Zio Monitor, Zio Xt Patch |
| Teleflex LLC | $17.64 | 2023 | Manta |
| Alon Medical Technology | $17.41 | 2025 | |
| Cardiva Medical, INC. | $16.64 | 2025 | Cardiva Vascade 6/7f Vcs |
| Inspire Medical Systems, INC. | $16.50 | 2025 | Inspire |
| Bayer Healthcare Pharmaceuticals INC. | $14.99 | 2024 | |
| Pfizer INC. | $13.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leigh Cochran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.